Terconazole
NDC 45802-717, Terconazole, suppository, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-717
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- SUPPOSITORY
- Route
- VAGINAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077149
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERCONAZOLE80 mg/1
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-717-08 | 45802071708 | 3 BLISTER PACK in 1 CARTON (45802-717-08) / 1 SUPPOSITORY in 1 BLISTER PACK (45802-717-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/207e9cf2-e8ec-43d7-9c11-46283c9cdb37NADAC price for package 45802071708
GET /v1/drugs/nadac/45802071708
Use it
Look up 45802-717 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.